A Quality Framework for Emergency Department Treatment of Opioid Use Disorder - 22/02/19
, Gail D’Onofrio, MD, MS b, Kristen Huntley, PhD c, Scott Levin, PhD d, Jeremiah D. Schuur, MD, MHS e, Gavin Bart, MD, PhD f, Kathryn Hawk, MD, MHS b, Betty Tai, PhD c, Cynthia I. Campbell, PhD, MPH g, Arjun K. Venkatesh, MD, MBA b, ⁎ 

Abstract |
Emergency clinicians are on the front lines of responding to the opioid epidemic and are leading innovations to reduce opioid overdose deaths through safer prescribing, harm reduction, and improved linkage to outpatient treatment. Currently, there are no nationally recognized quality measures or best practices to guide emergency department quality improvement efforts, implementation science researchers, or policymakers seeking to reduce opioid-associated morbidity and mortality. To address this gap, in May 2017, the National Institute on Drug Abuse’s Center for the Clinical Trials Network convened experts in quality measurement from the American College of Emergency Physicians’ (ACEP’s) Clinical Emergency Data Registry, researchers in emergency and addiction medicine, and representatives from federal agencies, including the National Institute on Drug Abuse and the Centers for Medicare & Medicaid Services. Drawing from discussions at this meeting and with experts in opioid use disorder treatment and quality measure development, we developed a multistakeholder quality improvement framework with specific structural, process, and outcome measures to guide an emergency medicine agenda for opioid use disorder policy, research, and clinical quality improvement.
Le texte complet de cet article est disponible en PDF.Plan
| Supervising editor: Donald M. Yealy, MD |
|
| Authorship: All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. |
|
| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org/). The authors have stated that no such relationships exist. Dr. Venkatesh is supported by the Yale Center for Clinical InvestigationKL2 TR000140 from the National Center for Advancing Translational Science, a component of the National Institutes of Health, and also works under contract with the Centers for Medicare & Medicaid Services (CMS) in the development of hospital outcome and efficiency quality measures. Drs. Schuur and Venkatesh are supported by CMS for leading the quality development work of the American College of Emergency Physicians’ (ACEP’s) Support and Alignment Network of the Transforming Clinical Practice Initiative. Drs. Schuur and Venkatesh are also supported by the Addiction Policy Forum in the development of a national quality improvement collaborative for emergency department–based quality improvement focused on opioids. |
|
| Disclaimer: The views and opinions expressed in this manuscript are those of the authors only and do not necessarily represent the views, official policy, or position of the US Department of Health and Human Services or any of its affiliated institutions or agencies. |
|
| A podcast for this article is available at www.annemergmed.com. |
Vol 73 - N° 3
P. 237-247 - mars 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
